ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study

Clinical trial NCT00745875 · COMPLETED

Trial details

NCT number: NCT00745875
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Lung Cancer

Start date: 2008-08-01
Primary completion: 2010-01-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.